{"url_path":"/sec/pepg/8-k/2026-05-21/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1835597/0001193125-26-233403-index.html","accession_number":"0001193125-26-233403","cik":"0001835597","ticker":"PEPG","issuer_name":"PepGen Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1835597/0001193125-26-233403-index.html","primary_entity_key":"0001835597","primary_entity_name":"PepGen Inc."},"word_count":160,"has_tables":true,"body_markdown":"Item 7.01\n\nRegulation FD Disclosure.\n\nOn May 21, 2026, PepGen Inc. (the “Company”) updated its Corporate Presentation in connection with its participation in the 15th International Myotonic Dystrophy Consortium being held May 26-30, 2026, a copy of which is being furnished as Exhibit 99.1 and incorporated herein by reference.\n\nThe information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in this Item 7.01 (including Exhibit 99.1)."}